|Bid||26.08 x 1000|
|Ask||26.11 x 1400|
|Day's Range||25.90 - 26.40|
|52 Week Range||8.05 - 30.25|
|Beta (5Y Monthly)||0.85|
|PE Ratio (TTM)||N/A|
|Earnings Date||Sep 27, 2021 - Oct 01, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||25.50|
AngioDynamics exceeded analyst expectations on revenue in Q4 2021, but does that make it worth buying?
AngioDynamics (ANGO) registers strong revenue growth across all its GBUs in fiscal 2021 Q4.
ANGO earnings call for the period ending May 31, 2021.